Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Frontage Holdings's Revenue for the
six
months ended in Dec. 2025 was $130.1 Mil. Frontage Holdings's average Accounts Receivable for the
six
months ended in Dec. 2025 was $63.0 Mil.
Hence, Frontage Holdings's Receivables Turnover for the
six
months ended in Dec. 2025 was 2.07.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Frontage Holdings Receivables Turnover Related Terms
Frontage Holdings Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Frontage Holdings's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FGHQF vs VRTX, REGN, ALNY: Receivables Turnover Comparison
For the Biotechnology subindustry, Frontage Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frontage Holdings Receivables Turnover vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Frontage Holdings's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Frontage Holdings's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Frontage Holdings (FGHQF) has a Receivables Turnover of 2.07 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Frontage Holdings and its competitors. According to the industry distribution chart, Frontage Holdings ranks #525 out of 841 companies in the Biotechnology industry, placing it in the top 62.4%.
Is Frontage Holdings' Receivables Turnover too high?
Frontage Holdings' current Receivables Turnover is 2.07. The Biotechnology industry median Receivables Turnover is 5.27. Frontage Holdings' value of 2.07 is 60.7% below this industry median. Based on the distribution chart, Frontage Holdings ranks #525 out of 841 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Frontage Holdings has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Frontage Holdings' Receivables Turnover compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Frontage Holdings ranks #525 out of 841 companies for Receivables Turnover. This places Frontage Holdings in the lower half of its industry. The industry median Receivables Turnover is 5.27. Frontage Holdings' value of 2.07 is 60.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.27, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Frontage Holdings's current Receivables Turnover of 2.07 is 60.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Frontage Holdings and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Frontage Holdings's current Receivables Turnover is 2.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frontage Holdings stock overvalued right now?
Based on GuruFocus' analysis, Frontage Holdings (FGHQF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.23, compared to a current price of $0.14 — trading 41.3% below its estimated fair value. The current Receivables Turnover is 2.07 and 60.7% below the Biotechnology industry median of 5.27. Frontage Holdings' overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Frontage Holdings (FGHQF), the current Receivables Turnover is 2.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Frontage Holdings (FGHQF) Overvalued in 2026?
Based on GuruFocus' analysis, Frontage Holdings stock appears to be undervalued.
The current stock price of $0.14 is trading 41.3% below its estimated GF Value™ of $0.23.
GuruFocus considers Frontage Holdings to be Significantly Undervalued.
Key valuation signals for FGHQF:
Receivables Turnover: 2.07
GF Value™: $0.23 vs. price of $0.14 (41.3% below fair value)
Industry Position: 60.7% below the Biotechnology median (#525 of 841)
No single metric tells the full story. See the FGHQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Frontage Holdings Corp provides laboratory and related services to pharmaceutical and agrochemical companies. Its segments include North America and Europe segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the USA, Canada and Europe; and PRC segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the PRC. It derives majority of the revenue from North America and Europe segment. Geographically majority of the revenue is derived from USA and Canada.
65GF Score
Get the complete analysis for FGHQF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FGHQF has been successfully added to your 
